Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lazarev

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Gastroenterology|December 25, 2008
Scope early and often in ulcerative colitis and Crohn's colitis?Thomas Ullman, Mark Lazarev
Digestive Diseases and Sciences|March 4, 2026
Muscle Matters: Sarcopenia, Visceral Adiposity, and Outcomes of Acute Severe Ulcerative ColitisLaura Maas, Mark Lazarev
Expert Opinion on Biological Therapy|December 2, 2017
Optimization of biologic therapy in Crohn's diseaseMohammed Razvi, Mark Lazarev
Gastrointestinal Endoscopy|January 17, 2017
ResponseAlyssa Parian, Mark Lazarev
Expert Review of Gastroenterology & Hepatology|January 17, 2015
Who and how to screen for cancer in at-risk inflammatory bowel disease patientsAlyssa Parian, Mark Lazarev
BMJ Case Reports|September 23, 2022
Cavitary lung nodules as an extraintestinal manifestation of ulcerative colitisNicole Paul, Mark Lazarev, Kristina Montemayor, et al.
Inflammatory Bowel Diseases|October 1, 2015
Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperStefan D Holubar, Jennifer Holder-Murray, Mark Flasar, et al.
Gastro Hep Advances|July 22, 2025
Care of Patients With Inflammatory Bowel Disease With Inadequate Response or Intolerance to UpadacitinibLynn Kobeissi, Kristi Briggs, Caya McFalls, et al.
Inflammatory Bowel Diseases|October 3, 2009
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care centerMark Lazarev, Thomas Ullman, Wolfgang H Schraut, et al.
Systematic Reviews|July 6, 2013
Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphomaSaranya A Selvaraj, Elizabeth Chairez, Lisa M Wilson, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Gastroenterology|December 25, 2008
Scope early and often in ulcerative colitis and Crohn's colitis?Thomas Ullman, Mark Lazarev
Digestive Diseases and Sciences|March 4, 2026
Muscle Matters: Sarcopenia, Visceral Adiposity, and Outcomes of Acute Severe Ulcerative ColitisLaura Maas, Mark Lazarev
Expert Opinion on Biological Therapy|December 2, 2017
Optimization of biologic therapy in Crohn's diseaseMohammed Razvi, Mark Lazarev
Gastrointestinal Endoscopy|January 17, 2017
ResponseAlyssa Parian, Mark Lazarev
Expert Review of Gastroenterology & Hepatology|January 17, 2015
Who and how to screen for cancer in at-risk inflammatory bowel disease patientsAlyssa Parian, Mark Lazarev
BMJ Case Reports|September 23, 2022
Cavitary lung nodules as an extraintestinal manifestation of ulcerative colitisNicole Paul, Mark Lazarev, Kristina Montemayor, et al.
Inflammatory Bowel Diseases|October 1, 2015
Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperStefan D Holubar, Jennifer Holder-Murray, Mark Flasar, et al.
Gastro Hep Advances|July 22, 2025
Care of Patients With Inflammatory Bowel Disease With Inadequate Response or Intolerance to UpadacitinibLynn Kobeissi, Kristi Briggs, Caya McFalls, et al.
Inflammatory Bowel Diseases|October 3, 2009
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care centerMark Lazarev, Thomas Ullman, Wolfgang H Schraut, et al.
Systematic Reviews|July 6, 2013
Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphomaSaranya A Selvaraj, Elizabeth Chairez, Lisa M Wilson, et al.
Pageof 6